Saima Sharif

Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2010 · 594 citations

Medicine, Oncology, Pharmacotherapy +16

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

Michael J. O’Connell, Linda H. Colangelo, Robert W. Beart et al. · Journal of Clinical Oncology · 2014 · 441 citations · Full text

Medicine, Oncology, Surgery +16

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · JNCI Journal of the National Cancer Institute · 2015 · 328 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2009 · 261 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial

Carmen J. Allegra, Greg Yothers, Michael J. O’Connell et al. · Journal of Clinical Oncology · 2012 · 208 citations

Medicine, Oncology, Pharmacotherapy +16